Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Treatment of Autoimmune Hepatitis
TORONTO, June 27, 2018 -- (Healthcare Sales &Marketing Network) -- Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) (FSE:31R) ("Revive" or the "Company"), a company focused on the research, development and commercialization of ... Biopharmaceuticals, FDA Revive Therapeutics, cannabinoid, autoimmune hepatitis, hepatitis
Objective The aim was to perform exploratory research on the application of technetium phytate (99mTc-Phy) portal perfusion index (PPI) imaging in predicting the complications of hepatitis B cirrhosis and their severity. Patients and methods A total of 65 hepatitis B cirrhosis patients were stratified, respectively, into three groups from classes A to C according to Child–Pugh scores and five groups from stages 1 to 5 according to the five-stage prognostic system. PPIs were compared and analyzed, respectively, among the three and five groups. The correlations between PPIs and major biochemical indices of liver f...
This article describes one university's endeavor to create and evaluate academic partnerships with HIV/hepatitis C virus primary care clinics in underserved settings. Designated preceptorships and specific preparation of students tailored for this population via online modules were strategies created to increase students' readiness to practice as primary care providers and increase clinical placements for nurse practitioner students. Outcomes include student readiness to practice and student satisfaction with clinics and preceptors. PMID: 30102259 [PubMed - in process]
Officials are again warning residents of a northeast Arkansas town of a possible hepatitis A exposure after an employee at a barbecue restaurant tested positive for the liver disease.
Authors: Altindis M, Demiray T, Koroglu M, Atasoy AR, Kesli R, Tosun S, Ozdemir M, Aksozek A, Ece G, Cetinkol Y, Altindis S, Guducuoglu H Abstract OBJECTIVE: Hepatitis C virus (HCV) infection is a major public health problem and affects large populations all over the world. Serum anti-HCV level is a valuable marker to determine HCV infection. Anti-HCV testing has been recommended for high-risk population. The Center for Disease Control (CDC) and Prevention in the United States proposed a new high-risk population group - adults born between 1945-1965. Under this perspective, we designed a multicentre retrospective s...
Hepatitis C blood born virus is a major cause of liver disease that more than three per cent of people in the world is dealing with, and the spread of hepatitis C virus (HCV) infection in different populations is one of the most important issues in epidemiology. In the present study, a new intelligent controller is developed and tested to control the hepatitis C infection in the population which the authors refer to as an optimal adaptive neuro-fuzzy controller. To design the controller, some data is required for training the employed adaptive neuro-fuzzy inference system (ANFIS) which is selected by the genetic algorithm....
Biological Reviews, EarlyView.
Journal of Cellular Biochemistry, EarlyView.
Author Correction: Ancient hepatitis B viruses from the Bronze Age to the Medieval period, Published online: 14 August 2018; doi:10.1038/s41586-018-0406-6Author Correction: Ancient hepatitis B viruses from the Bronze Age to the Medieval period
Journal of Viral Hepatitis, EarlyView.